Flanagan, S.E.

patient sulfonylurea diabetes mutation transfer insulin kir 6.2 mutations 6.2 treatment kir 6.2 patients discoloration 1 patients glibenclamide effect tooth discoloration 1 mutations tooth kcnj 11 mutation sulfonylurea therapy channel glyburide ashcroft fm glycemic control month hattersley control sulfonylurea treatment therapy ellard children teeth flanagan hospital study cause glycemic feature number kir 6.2 side effects gloyn al glibenclamide dose blood fl ow fi ve patients volume sulfonylurea receptor 1 research novel side effect university methods — edghill el ashcroft sulfonylurea dose diabetes care insulin secretion polak m 27 patients 2 months table gloyn result receptor pearson protocol proks p enamel sulfonylurea doses patient 2 froguel p sex birth weight range comparison equivalent glyburide dose diabetes mellitus february atp-sensitive fi rst year cave h level